Literature DB >> 19254462

[Effects of experimental liver injury on the intestinal barrier in rats.].

Ying Yao1, Zhi-Yuan Xu, Xue-Ping Chen, Li-Juan Shen, Jian-Peng Gao, Li-Ying You, Jin-Hui Yang.   

Abstract

OBJECTIVE: To study the effects of experimental liver injury on the intestinal barrier, and to evaluate the significance of plasma D(-)-lactate, diamine oxidase (DAO) and endotoxin in live injury.
METHODS: Fifty-five rats were randomized into the acute liver failure group (group C, n = 25), acute liver injury group (group B, n = 15), and control group (group A, n = 15). The concentrations of D(-)-lactate, DAO and endotoxin in plasma were detected by spectrophotograph. The morphology and subcellular structure were observed under optical microscope and transmission electron microscope.
RESULTS: Acute liver failure and acute liver injury models were established successfully. The concentrations of D(-)-lactate and DAO in the plasma of experimental groups (group B and C) were significantly higher than those in the control group (P less than 0.05); the concentration of intestinal DAO in experimental groups were significantly lower than that in the control group (P less than 0.05); the level of endotoxin in C group was significantly higher than that in group A and group B (P less than 0.05).
CONCLUSION: Liver injury induces hyperpermeability of the rat intestinal mucosal barrier, plasma D(-)-lactate and DAO are sensitive markers for early diagnosis of liver injury, plasma endotoxin may accelerate deterioration of liver function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19254462

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN: 1007-3418


  1 in total

1.  Effect of Montmorillonite powder on intestinal mucosal barrier in children with abdominal Henoch-Schonlein purpura: A randomized controlled study.

Authors:  Xiaolin Gao; Ruixue Miao; Yuhong Tao; Xiuying Chen; Chaomin Wan; Ruizhen Jia
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.